🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Using Bioimpedance Analysis to Monitor Fluid Status in Children

Recruitingn/aAges 6 Years - 21 YearsAllSt. Jude Children's Research Hospital
NCT07834710 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to develop a more comprehensive approach to monitoring fluid status in patients undergoing stem cell transplantation by combining conventional methods with a bioimpedance device.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Ages 6-21 years planned to undergo allogeneic or autologous HSCT for any indication with any preparative regimen. Exclusion Criteria: * Pacemaker implantation due to incompatibility with the bioimpedance device * Lack of agreement from the primary HSCT physician. * Inability or unwillingness of the research participant and/or legal guardian/representative to provide written informed consent.
💊

What it tests

  • Bioimpedance device
📍

Where

1 site
St. Jude Children's Research Hospital
Memphis, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy